at the selling price of Baht 800 million for the 3rd quarter period of 2018. E-Commerce segment Revenue from e-commerce segment in relation to e-Payment services decreased due mainly to high business

   Securities and Exchange Act 2535   98 12/03/1992 16/05/1992 2. Notification of Capital Market Supervisory Board  TorThor. 9/2554 Short Selling of ETF and Securities Being Underlying of ETF by a Securities

%) (18.75) -18% 3. Other income 2.06 3.42 8.31 (1.36) -40% 4. Selling expenses, administrative expenses and financial cost 63.99 63.97 55.22 0.02 0% 5. Income tax expenses 7.23 9.96 9.60 (2.73) -27% 6. Net

Q1’20 Q1’19 %Chg As Reported (% to Sales) Total SG&A Exp. 111(22.5%) 95(14.6%) 15.8% TKS 51(10.3%) 49(7.5%) 3.2% TBSP 60(12.2%) 46(7.1%) 29.2% For the 1st quarter 2020, Company reported Selling and

Baht) Q1 ended 31 March % changes 2020 2019 Increase (decrease) Sales 123,224 169,361 (27.24) Total revenues 135,209 181,787 (25.62) Cost of sales 114,031 166,753 (31.62) Selling and administrative

Ramkhamhaeng has revenue from selling medical supply and equipment 173.78 million baht, which increase 22.85 million baht from the previous year. 1.3 In the year 2020, Ramkhamhaeng Hospital Public Company

%) Other income 58 20 38 186% Selling and Administrative expenses (376) (620) (244) (39%) Net impairment losses on financial assets (56) - (56) Finance costs (38) (58) (20) (35%) Share of profit (loss) from

2020, the net profit of the Company and its subsidiary was 443.50 million baht. The total income was 1,046.19 million baht, financial cost was 286.71 million baht, the selling and administrative expense

Ramkhamhaeng has revenue from selling medical supply and equipment 222.16 million baht, which increase 96.64 million baht from the previous year. 1.3 In the year 2020, Ramkhamhaeng Hospital Public Company

export sales volume was dropped including the reduction of selling price. The fluctuation of raw material price and keen competition of selling price affected to the domestic sales whereas the appreciation